Hot topics | Coronavirus pandemic

Adverum Biotechnologies, Inc (ADVM) July 20, 2021 Stock Price, Analysis & Forecast

Adverum Biotechnologies, Inc (ADVM) July 20, 2021 Stock Price, Analysis & Forecast

Adverum Biotechnologies, Inc (NASDAQ: ADVM) opened the trading session on July 20, 2021, at $2.99, demonstrating a change of 5.0676% compared to the previous close at $2.96. Within the trading session, the stock price jumped to $3.12 and sunk to $2.96. Finally, the stock arranged at $3.11. However, taking into consideration a distant prospect, Adverum Biotechnologies, Inc reported a 52 Week Range within the ambit of $2.935-$19.25.

Adverum Biotechnologies, Inc's shares outstanding currently price $97.94M, as well as with a float of $61.96M. ADVM operates in the LIFE SCIENCES sector of the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry and has a market capitalization of $304.58M (as of July 20, 2021). It should be stressed that Adverum Biotechnologies, Inc's 50-day Moving Average arranged at $3.51, while such value as 200-day Moving Average is presently $8.18.

To estimate the company's efficiency, let's consider Adverum Biotechnologies, Inc's conglomerate performance. So far, ADVM has full-time employees. Adverum Biotechnologies, Inc has generated $inf per worker Within the last fiscal year. In the interim, ADVM's income per employee was $inf. And now, let's consider the company's income report. Adverum Biotechnologies, Inc's Net Income for the last fiscal year was $-64,486,000, while such value as Income Before Taxes was at the level of $-64,486,000. ADVM's Operating Income was at the mark of $-68,545,000.

Adverum Biotechnologies, Inc (ADVM) Earnings & Revenue

Talking about the Profitability, ADVM reached a Profit Margin of 0% and an Operating Margin (TTM) of -1637%. However, when we touch the questions of management effectiveness, Adverum Biotechnologies, Inc generated a Return on Equity (TTM) of -34.2% and a Return on Assets (TTM) of -19%. A bit more income statements might bring clarity to our overview. According to the results of the latest quarter ended March 31, 2021, Adverum Biotechnologies, Inc generated Revenue (TTM) of $7.50M, reporting a Quarterly Revenue Growth of -70%. As for the Revenue Per Share (TTM), this indicator was at the mark of $0.082. The company's Gross Profit (TTM) was $-73,309,000, while according to the EBITDA report, it was estimated at $-59,744,000.

Adverum Biotechnologies, Inc (NASDAQ: ADVM) Owners & Shares

Finally, let's take a look at the share statistics. As mentioned above, ADVM's shares outstanding now amounts to $97.94M, where Shares Short was $11.20M versus the prior month amounted to $8.54M. (Short % of Float was 18.1%). And now, let's overview which kind of investors works with Adverum Biotechnologies, Inc's stocks. ADVM's current ownership accounts for 100.42% institutional investors, while 0.809% of shares belong to the insiders. Also worth mentioning some indicators affecting dividends & splits. Thus, ADVM's Forward Annual Dividend Rate is currently at the mark of 0, whereas the Dividend Yield is 0%, and a Dividend Payout Ratio is 0% (Dividend Date: December 31, 1969). The company's Dividend Per Share value thereby is $None.

ADVM Trading Performance

It's time to observe the current performance indicators for Adverum Biotechnologies, Inc. ADVM's price/earnings to growth ratio during the last reported quarter was 0%. The company's PE Ratio stands at None%, while ADVM's Beta score is 1.186. Also worth noting that Adverum Biotechnologies, Inc's Diluted EPS (Earnings per Share) trailing twelve months is at the mark of -1.35. Other valuable indicators are Price To Sales Ratio (TTM), which is currently recorded at 35.97, as well as Price To Book Ratio, which amounts to 0.699.

Adverum Biotechnologies, Inc Analysis & Estimates

Within the previous 9-day period, Adverum Biotechnologies, Inc's Average True Range (ATR) was 0.1632, while the stock's Stochastic SlowD moving average was 12.4098%, and the SlowK moving average volumed at 12.4098%.

You may also like: